The effectiveness of insulin glargine 300 U/ml among type 2 diabetes patients: analysis of a real world data

被引：0
|
作者：
Cohen, C. Melzer [1 ]
Shalev, V. [1 ,2 ]
Chodick, G. [1 ,2 ]
机构：
[1] Maccabi Healthcare Serv, Maccabi Inst Res & Innovat, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
895
引用
收藏
页码：S436 / S437
页数：2
相关论文
共 50 条
  • [1] The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real-world data in Israel
    Cohen, Cheli Melzer
    Banon, Tamar
    Shalev, Varda
    Chodick, Gabriel
    [J]. ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (03)
  • [2] Improved Glycemic Control with Insulin Glargine 300 U/mL (Toujeo®) in Patients with Type 2 Diabetes: Real-World Effectiveness in Switzerland
    Peter Wiesli
    Marcus Schories
    [J]. Diabetes Therapy, 2018, 9 : 2325 - 2334
  • [3] Improved Glycemic Control with Insulin Glargine 300U/mL (Toujeo®) in Patients with Type 2 Diabetes: Real-World Effectiveness in Switzerland
    Wiesli, Peter
    Schories, Marcus
    [J]. DIABETES THERAPY, 2018, 9 (06) : 2325 - 2334
  • [4] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naive People with Type 2 Diabetes: the ATOS Study
    Galstyan, Gagik R.
    Tirosh, Amir
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen
    Coudert, Mathieu
    Naqvi, Mubarak
    Pilorget, Valerie
    Khan, Niaz
    [J]. DIABETES THERAPY, 2022, 13 (06) : 1187 - 1202
  • [5] A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes
    Tibaldi, Joseph
    Hadley-Brown, Martin
    Liebl, Andreas
    Haldrup, Steffen
    Sandberg, Viktor
    Wolden, Michael L.
    Rodbard, Helena W.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 1001 - 1009
  • [6] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
    Gagik R. Galstyan
    Amir Tirosh
    Hernando Vargas-Uricoechea
    Maria Aileen Mabunay
    Mathieu Coudert
    Mubarak Naqvi
    Valerie Pilorget
    Niaz Khan
    [J]. Diabetes Therapy, 2022, 13 : 1187 - 1202
  • [7] Effectiveness and safety of insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes after failure of oral therapy in a real-world setting
    Pfohl, Martin
    Jornayvaz, Francois R.
    Fritsche, Andreas
    Pscherer, Stefan
    Anderten, Helmut
    Pegelow, Katrin
    Seufert, Jochen
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (05): : 759 - 766
  • [8] CONFIRM: a comparative effectiveness study of insulin degludec and insulin glargine 300 units/ ml (glargine U300) in insulin-naive patients with type 2 diabetes
    Tibaldi, J.
    Haldrup, S.
    Sandberg, V.
    Wolden, M. L.
    Rodbard, H. W.
    [J]. DIABETOLOGIA, 2018, 61 : S44 - S44
  • [9] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA
    Bogdanovic, M.
    Fournier, M.
    Vitezic, D.
    [J]. VALUE IN HEALTH, 2018, 21 : S131 - S132
  • [10] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN BULGARIA
    Bogdanovic, M.
    Mihajlovic, J.
    Fournier, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S133 - S133
12345